Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;59(4):2466-9.
doi: 10.1128/AAC.05127-14. Epub 2015 Feb 9.

Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy

Affiliations

Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy

G Piccinelli et al. Antimicrob Agents Chemother. 2015 Apr.

Abstract

Of 901 group B streptococcus strains analyzed, 13 (1.4%) were resistant to levofloxacin (MICs of >32 μg/ml for seven isolates, 2 μg/ml for four isolates, and 1.5 μg/ml for four isolates). Mutations in the quinolone resistance-determining regions (QRDRs) of gyrase and topoisomerase IV were identified. A double mutation involving the Ser-81 change to Leu for gyrA and the Ser-79 change to Phe or to Tyr for parC was linked to a high level of fluoroquinolone resistance. In addition, two other mutational positions in parC were observed, resulting in an Asp-83-to-Tyr substitution and an Asp-83-to-Asn substitution. Different mutations were also observed in gyrB, with unknown significance. Most levofloxacin-resistant GBS strains were of serotype Ib and belonged to sequence type 19 (ST19) and clonal complex 19 (CC-19). Most of them exhibited the epsilon gene.

PubMed Disclaimer

References

    1. Heath PT, Schuchat A. 2007. Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol 21:411–427. doi:10.1016/j.bpobgyn.2007.01.003. - DOI - PubMed
    1. Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, Albanese BA, Stefonek K, Zell ER, Jackson D, Thompson T, Schrag SJ. 2009. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 49:85–92. doi:10.1086/599369. - DOI - PubMed
    1. Nagano N, Nagano Y, Toyama M, Kimura K, Tamura T, Shibayama K, Arakawa Y. 2012. Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J Antimicrob Chemother 67:849–856. doi:10.1093/jac/dkr546. - DOI - PubMed
    1. Kimura K, Suzuki S, Wachino J, Kurokawa H, Yamane K, Shibata N, Nagano N, Kato H, Shibayama K, Arakawa Y. 2008. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890–2897. doi:10.1128/AAC.00185-08. - DOI - PMC - PubMed
    1. Heelan JS, Hasenbein ME, McAdam AJ. 2004. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol 42:1263–1264. doi:10.1128/JCM.42.3.1263-1264.2004. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources